Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 6: 24032, 2016 Apr 06.
Article in English | MEDLINE | ID: mdl-27049119

ABSTRACT

Proteasome-catalyzed peptide splicing represents an additional catalytic activity of proteasomes contributing to the pool of MHC-class I-presented epitopes. We here biochemically and functionally characterized a new melanoma gp100 derived spliced epitope. We demonstrate that the gp100(mel)47-52/40-42 antigenic peptide is generated in vitro and in cellulo by a not yet described proteasomal condensation reaction. gp100(mel)47-52/40-42 generation is enhanced in the presence of the ß5i/LMP7 proteasome-subunit and elicits a peptide-specific CD8(+) T cell response. Importantly, we demonstrate that different gp100(mel)-derived spliced epitopes are generated and presented to CD8(+) T cells with efficacies comparable to non-spliced canonical tumor epitopes and that gp100(mel)-derived spliced epitopes trigger activation of CD8(+) T cells found in peripheral blood of half of the melanoma patients tested. Our data suggest that both transpeptidation and condensation reactions contribute to the frequent generation of spliced epitopes also in vivo and that their immune relevance may be comparable to non-spliced epitopes.


Subject(s)
Alternative Splicing , Epitopes/chemistry , Proteasome Endopeptidase Complex/metabolism , gp100 Melanoma Antigen/chemistry , Algorithms , Antigen Presentation/immunology , Antigens/chemistry , Antigens, Neoplasm/immunology , CD8-Positive T-Lymphocytes/cytology , Case-Control Studies , Catalysis , Cell Line, Tumor , Epitopes, T-Lymphocyte/immunology , HeLa Cells , Humans , Interferon-gamma/metabolism , Melanocytes/cytology , Melanoma/metabolism , Peptides/chemistry , Probability , Proteasome Endopeptidase Complex/chemistry
2.
Curr Pharm Des ; 16(7): 802-13, 2010.
Article in English | MEDLINE | ID: mdl-20388091

ABSTRACT

Human aging and longevity are complex and multi-factorial traits that result from a combination of environmental, genetic, epigenetic and stochastic factors, each contributing to the overall phenotype. The multi-factorial process of aging acts at different levels of complexity, from molecule to cell, from organ to organ systems and finally to organism, giving rise to the dynamic "aging mosaic". At present, an increasing amount of experimental data on genetics, genomics, proteomics and other -omics are available thanks to new high-throughput technologies but a comprehensive model for the study of human aging and longevity is still lacking. Systems biology represents a strategy to integrate and quantify the existing knowledge from different sources into predictive models, to be later tested and then implemented with new experimental data for validation and refinement in a recursive process. The ultimate goal is to compact the new acquired knowledge into a single picture, ideally able to characterize the phenotype at systemic/organism level. In this review we will briefly discuss the aging phenotype in a systems biology perspective, showing four specific examples at different levels of complexity, from a systemic process (inflammation) to a cascade-process pathways (coagulation) and from cellular organelle (proteasome) to single gene-network (PON-1), which could also represent targets for anti-aging strategies.


Subject(s)
Aging/physiology , Longevity/physiology , Systems Biology , Age Factors , Drug Design , Humans , Models, Biological
3.
Eur J Surg Oncol ; 35(4): 415-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18468835

ABSTRACT

OBJECTIVES: p53 Gene variants BstUI RFLP at codon 72 in exon 4, 16bp tandem repeat in intron 3 and MspI RFLP in intron 6, which code for two functionally different protein isoforms, have been shown to modulate susceptibility to different types of human neoplasms. METHODS: p53 genotype was assessed in 90 CRC patients, 321 age-matched controls and 322 centenarians. RESULTS: The p53 codon 72 arginine, the p53 16bp deletion, and the MspI RFLP were significantly more frequent in CRC patients in comparison to the controls and to the centenarians (odd ratio 1.44 and 1.93). In the CRC group, the BstUI RFLP polymorphism was the more frequent combination (62.2%), and it was significantly associated with highly infiltrating (p<0.01), poorly differentiated (p<0.01), and metastatic (p<0.05) tumours. Our findings indicate that the p53 codon 72 polymorphisms are associated with a higher risk of CRC and are associated with more advanced and undifferentiated tumours.


Subject(s)
Adenocarcinoma/genetics , Colorectal Neoplasms/genetics , Polymorphism, Genetic , Tumor Suppressor Protein p53/genetics , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Adult , Aged , Aged, 80 and over , Case-Control Studies , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Disease Progression , Female , Gene Frequency , Genotype , Humans , Male , Middle Aged , Odds Ratio , Risk Assessment
4.
Free Radic Res ; 40(12): 1303-23, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17090420

ABSTRACT

Many epidemiological data indicate the presence of a strong familial component of longevity that is largely determined by genetics, and a number of possible associations between longevity and allelic variants of genes have been described. A breakthrough strategy to get insight into the genetics of longevity is the study of centenarians, the best example of successful ageing. We review the main results regarding nuclear genes as well as the mitochondrial genome, focusing on the investigations performed on Italian centenarians, compared to those from other countries. These studies produced interesting results on many putative "longevity genes". Nevertheless, many discrepancies are reported, likely due to the population-specific interactions between gene pools and environment. New approaches, including large-scale studies using high-throughput techniques, are urgently needed to overcome the limits of traditional association studies performed on a limited number of polymorphisms in order to make substantial progress to disentangle the genetics of a trait as complex as human longevity.


Subject(s)
Aging/genetics , Genes , Longevity/genetics , Aged, 80 and over , Animals , Apolipoprotein E4/genetics , Apolipoproteins/genetics , Aryldialkylphosphatase/genetics , Clusterin/genetics , Cytokines/genetics , DNA, Mitochondrial/genetics , Humans , Inflammation/genetics , Insulin-Like Growth Factor I/genetics , Poly(ADP-ribose) Polymerases/genetics , Polymorphism, Genetic , Proteasome Endopeptidase Complex/physiology , Superoxide Dismutase/genetics , Tumor Suppressor Protein p53/genetics
5.
Cell Death Differ ; 11(9): 962-73, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15131588

ABSTRACT

A common arginine to proline polymorphism is harboured at codon 72 of the human p53 gene. In this investigation, we found that fibroblasts and lymphocytes isolated from arginine allele homozygote centenarians and sexagenarians (Arg+) undergo an oxidative-stress-induced apoptosis at a higher extent than cells obtained from proline allele carriers (Pro+). At variance, the difference in apoptosis susceptibility between Arg+ and Pro+ is not significant when cells from 30-year-old people are studied. Further, we found that Arg+ and Pro+ cells from centenarians differ in the constitutive levels of p53 protein and p53/MDM2 complex, as well as in the levels of oxidative stress-induced p53/Bcl-xL complex and mitochondria-localised p53. Consistently, all these differences are less evident in cells from 30-year-old people. Finally, we investigated the in vivo functional relevance of the p53 codon 72 genotype in a group of old patients (66-99 years of age) affected by acute myocardial ischaemia, a clinical condition in which in vivo cell death occurs. We found that Arg+ patients show increased levels of Troponin I and CK-MB, two serum markers that correlate with the extent of the ischaemic damage in comparison to Pro+ patients. In conclusion, these data suggest that p53 codon 72 polymorphism contributes to a genetically determined variability in apoptotic susceptibility among old people, which has a potentially relevant role in the context of an age-related pathologic condition, such as myocardial ischaemia.


Subject(s)
Apoptosis , Codon , Genes, p53 , Ischemia , Tumor Suppressor Protein p53/physiology , Adult , Age Factors , Aged , Aged, 80 and over , Alleles , Arginine , Blotting, Western , Cell Death , Creatine Kinase/blood , Creatine Kinase, MB Form , Dose-Response Relationship, Drug , Female , Fibroblasts/metabolism , Flow Cytometry , Genotype , Homozygote , Humans , Immunoprecipitation , Isoenzymes/blood , Leukocytes/metabolism , Lymphocytes/metabolism , Male , Membrane Potentials , Microscopy, Fluorescence , Middle Aged , Myocardial Ischemia/pathology , Oxidative Stress , Polymorphism, Genetic , Proline , Proto-Oncogene Proteins c-bcl-2 , Regression Analysis , Serine/chemistry , Time Factors , Transfection , Troponin I/blood , bcl-X Protein
6.
Exp Gerontol ; 37(2-3): 301-8, 2002.
Article in English | MEDLINE | ID: mdl-11772516

ABSTRACT

As a consequence of inflammatory stimuli (such as TNFalpha and IFNgamma), some constitutive subunits of the proteasome, the principal mediator of nonlysosomal protein degradation, are replaced with other subunits, the large multifunctional proteases LMP2 and LMP7, thus originating the immunoproteasome. An age-related alteration of proteasome activity and susceptibility to TNFalpha-induced apoptosis, in which LMP2 and the nuclear factor (NF)-kappaB activation play an important role has been recently reported. In this paper, we investigated the possible influence of two LMP2 and LMP7 polymorphisms on susceptibility to TNFalpha-induced apoptosis. Our data show that an increase in susceptibility to TNFalpha-induced apoptosis is evident in long-lived people (aged >88 years) in comparison to young individuals. Moreover, the modulation of LMP2 codon 60 polymorphism on TNFalpha-induced apoptosis is evident in long-lived subjects. Genotyping of 311 young people and 157 nonagenarians and centenarians revealed no changes in LMP2 codon 60 genotype frequency distribution. No correlation with TNFalpha-induced apoptosis and no difference in frequency between young people and nonagenarians/centenarians was observed when the LMP7 nucleotide 145 polymorphism was studied.


Subject(s)
Aging/genetics , Apoptosis/genetics , Cysteine Endopeptidases , Major Histocompatibility Complex/genetics , Multienzyme Complexes , Polymorphism, Genetic , Proteins/genetics , Adult , Aged , Aged, 80 and over , Aging/immunology , Apoptosis/immunology , Cells, Cultured , Humans , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Longevity , Proteasome Endopeptidase Complex , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...